Treatment of migraine; with special reference to ergotamine tartrate-caffeine rectal suppositories.
D002110:Caffeine / Q000627:therapeutic use*; D002317:Cardiovascular Agents; D004876:Ergot Alkaloids / Q000627:therapeutic use*; D004878:Ergotamine; D006801:Humans; D008881:Migraine Disorders / Q000628:therapy*; D013488:Suppositories; D013644:Tartrates
D002317:Cardiovascular Agents; D004876:Ergot Alkaloids; D013488:Suppositories; D013644:Tartrates; D002110:Caffeine; D004878:Ergotamine; C029768:tartaric acid
CAFFEINE/therapeutic use; ERGOT ALKALOIDS/therapeutic use; MIGRAINE/therapy